In a clinical trial, participants with a BMI of 30 or higher, or 27 or higher with at least one weight-related health condition, experienced an average weight loss of 14.9% over 68 weeks.

 

Important Information:

While we do not manufacture FDA-approved medications such as Wegovy® and Ozempic®, which are products of Novo Nordisk™, we offer our clients the option to select these medications, which are supplied through our partner pharmacies.

For compounded semaglutide, our operations involve collaboration with sterile compounding pharmacies. These pharmacies adhere to rigorous inspections. Compounded medications are tailored based on a practitioner's prescription for individual patients and are not FDA-approved. This makes it difficult to directly compare the efficacy and safety profiles of compounded medications with FDA-approved ones, due to variations in strength, dosage, and other factors. The decision to prescribe any compounded medication is made by a licensed clinician, who evaluates the patient’s needs through telemedicine consultations and a review of their medical history.

Please note that making a payment does not ensure that a prescription will be written or dispensed. AK TWISTED WELLNESS does not directly provide medical or pharmacy services; instead, we collaborate with healthcare professionals who operate on HIPAA-compliant platforms to offer these services. The content on this website is intended solely for informational purposes and should not replace professional medical advice, assessments, or treatments. If you have any health-related questions or concerns, please consult your doctor.